As of March 31, 2026, Oxford Biodynamics PLC carries a market capitalization of 8.32M, placing it among publicly traded companies globally. Its enterprise value stands at 10.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.32M |
| Enterprise Value | 10.65M |
Oxford Biodynamics PLC's next confirmed earnings release is scheduled for January 26, 2027.
| Earnings Date | 1/26/2027 |
As of March 31, 2026, Oxford Biodynamics PLC has 4.29B shares outstanding.
| Shares Outstanding | 4.29B |
These figures are as of March 31, 2026.
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.90 |
As of March 31, 2026, Oxford Biodynamics PLC maintains a current ratio of 2.01, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.01 |
| Quick Ratio | 1.32 |
| Debt / Equity | 131.61 |
As of the close on November 16, 2026, Oxford Biodynamics PLC's stock has declined approximately 28.57% over the past 52 weeks.
| 52-Week Price Change | -28.57% |
| 50-Day Moving Average | 0.03 |
As of March 31, 2026, Oxford Biodynamics PLC holds 3.32M in cash and equivalents against 5.66M in total debt, resulting in a net debt position of -3.32M. Total book value stands at 4.30M, with working capital of 2.53M providing operational flexibility.
| Cash & Cash Equivalents | 3.32M |
| Total Debt | 5.66M |
| Net Debt | -3.32M |
| Equity (Book Value) | 4.30M |
| Working Capital | 2.53M |
Already premium?